Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewArcaine sulfate
Description: Competitive NMDA antagonist
Chemical Name: N,N'-1,4-Butanediylbisguanidine sulfate
Purity: ≥99% (HPLC)
Biological Activity for Arcaine sulfate
Arcaine sulfate is a NO synthase inhibitor. An NMDA antagonist acting as a competitive inhibitor at the polyamine site.
Technical Data for Arcaine sulfate
| M. Wt | 270.31 |
| Formula | C6H16N6.H2SO4 |
| Storage | Store at RT |
| Purity | ≥99% (HPLC) |
| CAS Number | 14923-17-2 |
| PubChem ID | 119020 |
| InChI Key | RWTGFMPOODRXIM-UHFFFAOYSA-N |
| Smiles | O=[SH2]([O])O[O].NC(NCCCCNC(N)=N)=N |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets for Arcaine sulfate
References for Arcaine sulfate
References are publications that support the biological activity of the product.
Doyle and Shaw (1998) Investigation of the actions and antagonist activity of some polyamine analogues in vivo. Br.J.Pharmacol. 124 386 PMID: 9641557
Reynolds (1990) Arcaine is a competitive antagonist of the polyamine site on the NMDA receptor. Eur.J.Pharmacol. 177 215 PMID: 2155812
Yokoi et al (1994) Structure-activity relationships of arginine analogues on nitric oxide synthase activity in the rat brain. Neuropharmacology 33 1261 PMID: 7532812
View Related Products by Target
View Related Products by Product Action
Keywords: Arcaine sulfate, Arcaine sulfate supplier, Competitive, NMDA, antagonists, Glutamate, Receptors, N-Methyl-D-Aspartate, iGluR, Ionotropic, 0389, Tocris Bioscience
Citations for Arcaine sulfate
Citations are publications that use Tocris products.
Currently there are no citations for Arcaine sulfate.
Reviews for Arcaine sulfate
There are currently no reviews for this product. Be the first to review Arcaine sulfate and earn rewards!
Have you used Arcaine sulfate?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Huntington's Disease Research Product Guide
This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:
- Somatic Instability
- Proteolysis and Inclusion Bodies
- Transcriptional Dysregulation
- Mitochondrial Dysfunction
- Nuclear-Cytoplasmic Transport Interference
- Excitotoxicity
- Stem Cells
Alzheimer's Disease Poster
Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Huntington's Disease Poster
Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Parkinson's Disease Poster
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.